Clinical nutrition: 7. Functional foods - More than just nutrition

CMAJ. Canadian Medical Association Journal

Volumn 166, Issue 12, 2002, Pages 1555-1563

  Jones, Peter J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; OMEGA 3 FATTY ACID; PLANT EXTRACT; PROBIOTIC AGENT; STANOL ESTER; STEROL;

ADULT; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; INTERNET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL HEALTH; OAT; PRESCRIPTION; REVIEW; SOYBEAN;

EID: 0036279913     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. The top ten functional food trends
2. Overview: Dietary approaches for reducing cardiovascular disease risks
3. Cholesterol-lowering effects of dietary fiber: A meta-analysis
4. Cereals, legumes, and chronic disease risk reduction: Evidence from epidemiologic studies
5. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: The Third National Health and Nutrition Examination Survey, Phase 1, 1988-1991
6. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
7. Sites and mechanisms for the hypocholesterolemic actions of soluble dietary fiber sources
8. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model
9. Fecal weight, colon cancer risk and dietary intake of nonstarch polysaccharide (dietary fiber)
10. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: Results of a controlled metabolic trial
11. Food labeling: Health claims; soy protein and coronary heart disease
12. Soy protein in the management of hyperlipidemia
13. Soy proteins and cardiovascular disease
14. Phyto-oestrogens and cardiovascular disease risk
15. Protection against breast cancer with genistein: A component of soy
16. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
17. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones
18. Effects of soy isoflavones on atherosclerosis: Potential mechanisms
19. Thrombotic mechanisms in atherosclerosis: Potential impact of soy proteins
20. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care
21. Role of essential fatty acids in the function of the developing nervous system
22. n-3 polyunsaturated fatty acid requirements of term infants
23. A case of human linolenic acid deficiency involving neurological abnormalities
24. Importance of n-3 fatty acids in health and disease
25. Lipids: Cellular metabolism
26. n-3 fatty acids and heart disease
27. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome
28. n-3 polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes
29. Use of fish oil to treat patients with immunoglobulin A nephropathy
30. Polyunsaturated fatty acids and inflammatory bowel disease
31. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids
32. n-3 fatty acid supplements in rheumatoid arthritis
33. Prebiotics and probiotics: Are they functional foods?
34. Protection from gastrointestinal diseases with the use of probiotics
35. Probiotics for humans
36. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells
37. The fate of ingested lactobacilli in the proximal small intestine
38. Consumption of fermented and non-fermented dairy products: Effects on cholesterol concentrations and metabolism
39. Probiotics: Effects on immunity
40. Protective role of probiotics and prebiotics in colon cancer
41. Fecal short chain fatty acids in South African urban Africans and whites
42. Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate
43. Serum, biliary, and fecal cholesterol and plant sterols in cholectomized patients before and during consumption of stanol ester margarine
44. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters
45. Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans
46. Plant sterols and their derivatives; the current spread of results
47. Plant sterol and stanol margarines and health
48. Beta-sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells
49. Effect of dietary phytosterols on cell proliferation and protein kinase C activity in rat colonic mucosa
50. β-sitosterol inhibits HT-29 human colon cancer cell growth and alters membrane lipids
51. β-sitosterol inhibits the growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle
52. β-sitosterol for treatment of benign prostate hyperplasia: A systematic review
53. Randomised placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia
54. Cancer statistics